Добірка наукової літератури з теми "Blood-brain barrier"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Blood-brain barrier".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Blood-brain barrier"
KANDA, Takashi. "Blood-Brain Barrier and Blood-Nerve Barrier." Yamaguchi Medical Journal 54, no. 1 (2005): 5–11. http://dx.doi.org/10.2342/ymj.54.5.
Повний текст джерелаShalaby, Mohamed Adel. "Blood-Brain Barrier." Al-Azhar Medical Journal 45, no. 3 (July 2016): i—vi. http://dx.doi.org/10.12816/0033115.
Повний текст джерелаLawther, Bradley K., Sajith Kumar, and Hari Krovvidi. "Blood–brain barrier." Continuing Education in Anaesthesia Critical Care & Pain 11, no. 4 (August 2011): 128–32. http://dx.doi.org/10.1093/bjaceaccp/mkr018.
Повний текст джерелаDunn, Jeff F., and Albert M. Isaacs. "The impact of hypoxia on blood-brain, blood-CSF, and CSF-brain barriers." Journal of Applied Physiology 131, no. 3 (September 1, 2021): 977–85. http://dx.doi.org/10.1152/japplphysiol.00108.2020.
Повний текст джерелаKoziara, J. M., P. R. Lockman, D. D. Allen, and R. J. Mumper. "The Blood-Brain Barrier and Brain Drug Delivery." Journal of Nanoscience and Nanotechnology 6, no. 9 (September 1, 2006): 2712–35. http://dx.doi.org/10.1166/jnn.2006.441.
Повний текст джерелаCho, Choi-Fong. "The Blood-Brain Barrier." Oncology Times 40, no. 2 (January 2018): 1. http://dx.doi.org/10.1097/01.cot.0000530114.97923.aa.
Повний текст джерелаMizee, Mark Ronald, and Helga Eveline de Vries. "Blood-brain barrier regulation." Tissue Barriers 1, no. 5 (December 2013): e26882. http://dx.doi.org/10.4161/tisb.26882.
Повний текст джерелаDobbing, John. "The Blood-Brain Barrier." Developmental Medicine & Child Neurology 3, no. 6 (November 12, 2008): 610–12. http://dx.doi.org/10.1111/j.1469-8749.1961.tb10430.x.
Повний текст джерелаDobbing, John. "The Blood-Brain Barrier." Developmental Medicine & Child Neurology 3, no. 4 (November 12, 2008): 311–14. http://dx.doi.org/10.1111/j.1469-8749.1961.tb15323.x.
Повний текст джерелаDaneman, Richard, and Alexandre Prat. "The Blood–Brain Barrier." Cold Spring Harbor Perspectives in Biology 7, no. 1 (January 2015): a020412. http://dx.doi.org/10.1101/cshperspect.a020412.
Повний текст джерелаДисертації з теми "Blood-brain barrier"
Podjaski, Cornelia. "Netrins enhance blood-brain barrier function and regulate immune responses at the blood-brain barrier." Thesis, McGill University, 2013. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=116977.
Повний текст джерелаAu cours du développement, les molécules de la famille des nétrines contribuent à la morphologénèse des organes en contrôlant la motilité et l'adhérence cellulaire. L'adhérence cellulaire entre les cellules endothéliales est une caractéristique importante de la barrière hémato-encéphalique (BHE), ce qui rend l'endothélium imperméable aux molécules sanguines et aux cellules immunitaires. Pour établir et maintenir cette barrière au cours du développement, à l'âge adulte et au cours de la maladie, les cellules endothéliales du cerveau doivent développer et maintenir ces contacts adhésifs en exprimant des molécules de jonction serrées. Cependant, nous ne savons pas si les molécules de la famille des nétrines influencent l'adhérence cellulaire inter-endothéliale de la BHE. Nous avons donc émis l'hypothèse que les nétrines resserrent la BHE au cours du développement, à l'âge adulte, et la protège au cours de la maladie.Méthodes: Pour valider notre hypothèse, nous avons utilisé des cellules endothéliales primaires dérivées des cerveaux humains adultes ou des cerveaux de souris nouveau-nés déficientes en nétrine-1 et évalué l'effet de la nétrine sur l'adhésion cellulaire endothéliale et inter-perméabilité de la barrière. Nous avons également évalué le potentiel thérapeutique des nétrines a restaurer la barrière et l'infiltration de cellules immunitaires limite dans le système nerveux central (SNC) pendant encéphalomyélite allergique expérimentale, un modèle animal de sclérose en plaques. Résultats: Nos résultats démontrent que les nétrines sont exprimées par les cellules endothéliales du cerveau, exprimes nétrines. Au cours du développement les nétrines aident à assurer l'étanchéité de la BHE. Chez les adultes, ils maintiennent et protègent la barrière adulte en augmentant l'expression des molécules de jonctions serrées, favorisant ainsi l'adhérence inter-endothéliale et diminuant les fuites de protéines à travers la BHE. Dans la pathologie de l'EAE, le rôle des nétrins diffère en fonction de la phase de la maladie. Au cours de la phase aigue, les nétrines atténuent la perte de l'intégrité de la BHE et diminuent l'infiltration des cellules myéloïdes dans le SNC. Ceci retarde l'apparition de la maladie et réduit sa sévérité. Au cours de la phase chronique de l'EAE, les souris traitées avec netrin-1 ont un plus grand nombre des cellules T activées dans leurs SNC et présentent une démarche ataxique ainsi qu'une spasticité des membres. Discussion: Nous concluons que les nétrins améliorent la stabilité de la BHE. Ces résultats suggèrent que les nétrines peuvent être envisagée comme agent thérapeutique dans les maladies neuroinflammatoire. Dans ce cas une approche précoce et à court terme serait probablement plus efficace.
Zhu, Chunni. "The Blood-brain barrier in normal and pathological conditions." Title page, abstract and contents only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phz637.pdf.
Повний текст джерелаBrownlees, Janet. "Some enzymes of the blood-brain barrier." Thesis, Queen's University Belfast, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334522.
Повний текст джерелаRaabe, Rebecca L. "Radiation effects on the blood-brain barrier." Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/44779.
Повний текст джерелаIncludes bibliographical references (p. 53-56).
Selective vascular irradiation enables the critical examination of the vasculature and its role in the onset of late radiation effects. It is a novel approach to expose the endothelial cells to much higher levels of ionizing radiation relative to normal cells by utilizing the boron neutron capture reaction. When boron-containing compounds are restricted to the lumen of the blood vessel, the resulting high-LET alpha and lithium particles cannot deposit their energy in the normal cells beyond the vasculature after the target is exposed to thermal neutrons. This allows for a 2- to 3-fold increase in the calculated dose to the endothelial cells. However, this technique has been criticized because there is no direct evidence that the endothelial cells receive an absorbed dose from the selective vascular irradiation. The objective of this work is to provide corroborating experimental evidence that selective vascular irradiation physically damages the endothelial cells. An established assay utilizing blood-brain barrier disruption was adopted to quantify the radiation damage to the endothelial cells in female BALB/C mice, 8-12 weeks of age. A dye that attaches to the plasma proteins in the blood and that is ordinarily kept out of the brain by the blood-brain barrier is injected into the blood supply before the irradiation, and following irradiation, damage to the vasculature will result in disruption of the blood-brain barrier that allows blood stained with the dye to enter the brain. After sacrificing, the blood in the vessel lumen is cleared by performing a trans-cardiac perfusion, and the brain is homogenized and prepared for analysis. The absorbance of the resulting supernatant of each brain sample is measured with a spectrophotometer at the optimal wavelength of the dye.
(cont.) The absorbance is related to the quantity of blood that leaked through the blood-brain barrier, which is also related to the damage caused to the vasculature from exposure to ionizing radiation. Increased leakage through the blood-brain barrier was observed for those mice exposed to selective vascular irradiation, indicating a direct relationship between the leakage through the blood-brain barrier and the 10B concentration in the blood. The most significant increase in the leakage through the blood-brain barrier (p<0.002) was observed at the highest lOB concentration in the blood (161 ppm). The compound biological effectiveness (CBE) for sulfhydryl borane (BSH) was calculated to be 0.28, which is consistent with the published value of the CBE for BSH in the rat spinal cord. This suggests that the assumptions used for calculating the absorbed doses for selective vascular irradiation are reasonable and approximate to what the endothelial cells receive.
by Rebecca L. Raabe.
S.M.
Lochhead, Jeffrey James. "Oxidative Stress Alters Blood-Brain Barrier Integrity." Diss., The University of Arizona, 2011. http://hdl.handle.net/10150/193873.
Повний текст джерелаArranz, Gibert Pol. "Blood-Brain Barrier Shuttles: From Design to Application." Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/401325.
Повний текст джерелаLa barrera hematoencefàlica (BHE) actua com a protecció del sistema nerviós central (SNC) regulant el transport de molècules d’una manera selectiva. Això dificulta el tractament de malalties que afecten al SNC, ja que la BHE també evita que fàrmacs que serien efectius no siguin transportats al cervell. Per això, s’estan desenvolupant mètodes que permetin enviar selectivament fàrmacs a través de la BHE. És el cas dels pèptids llançadora. Aquests es poden dissenyar per creuar per algun dels mecanismes de transport existents en la BHE. En aquesta tesi es desenvolupen uns pèptids que creuen per difusió passiva (basats en fenilprolines), que respecte al disseny anterior (basats en N‐ metilfenilalanines) milloren la solubilitat en aigua en tres ordres de magnitud i al transport un cop s’hi enganxa el fàrmac. Per una altra banda, es desenvolupa una metodologia per a la quantificació del transport basada en la combinació d’espectrometria de masses MALDI‐TOF amb models de BHE in vitro (cel∙lulars), millorant la sensibilitat respecte a la detecció per RP‐HPLC‐PDA en tres ordres de magnitud. L’avaluació d’una peptidoteca derivada d’un pèptid llançadora mitjançant aquesta metodologia permet el descobriment de dos anàlegs del pèptid original que milloren el transport. Addicionalment, s’estudia la immunogenicitat de pèptids llançadora formats per aminoàcids L o D. S’observa que encara que ambdós mostren una baixa immunogenicitat, la resposta dels pèptids amb aminoàcids D és encara menor. Finalment, s’estudia de forma preliminar la possibilitat de desenvolupar una teràpia de reemplaçament proteic i una teràpia gènica per atàxia de Friedreich al SNC mitjançant l’ús de pèptids llançadora.
Chen, Bo. "Role of blood-brain barrier leakage during stroke." Diss., [La Jolla] : University of California, San Diego, 2010. http://wwwlib.umi.com/cr/ucsd/fullcit?p3403853.
Повний текст джерелаEdrissi, Hamidreza. "Blood Brain Barrier Dysfunction in Chronic Cerebral Ischemia." Thesis, Université d'Ottawa / University of Ottawa, 2015. http://hdl.handle.net/10393/32531.
Повний текст джерелаOwe-Young, Robert School of Medicine UNSW. "Kynurenine pathway metabolism at the blood-brain barrier." Awarded by:University of New South Wales. School of Medicine, 2006. http://handle.unsw.edu.au/1959.4/26183.
Повний текст джерелаBénardais, Karelle [Verfasser]. "Modulation of the blood-brain barrier / Karelle Bénardais." Hannover : Bibliothek der Tierärztlichen Hochschule Hannover, 2013. http://d-nb.info/1037791665/34.
Повний текст джерелаКниги з теми "Blood-brain barrier"
Nag, Sukriti. Blood-Brain Barrier,. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592594190.
Повний текст джерелаKobiler, David, Shlomo Lustig, and Shlomo Shapira, eds. Blood—Brain Barrier. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-0579-2.
Повний текст джерелаBarichello, Tatiana, ed. Blood-Brain Barrier. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-8946-1.
Повний текст джерелаR, Helio Tomas, ed. The blood brain barrier. New York: Nova Science Publishers, 2008.
Знайти повний текст джерелаStone, Nicole, ed. The Blood-Brain Barrier. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2289-6.
Повний текст джерелаJ, Suckling Anthony, Rumsby M. G, and Bradbury M. W. B, eds. The Blood-brain barrier in health and disease. Chichester [Essex], England: E. Horwood, 1986.
Знайти повний текст джерелаMontenegro, Pedro A. The blood-brain barrier: New research. Hauppauge, N.Y: Nova Science Publishers, 2011.
Знайти повний текст джерелаFricker, Gert, Melanie Ott, and Anne Mahringer, eds. The Blood Brain Barrier (BBB). Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43787-2.
Повний текст джерелаA, Neuwelt Edward, ed. Implicationsof the blood-brain barrier and its manipulation. New York: Plenum Medical, 1989.
Знайти повний текст джерелаPierre-Olivier, Couraud, Scherman Daniel, and Cerebral Vascular Biology Symposium (1995 : Paris, France), eds. Biology and physiology of the blood-brain barrier: Transport, cellular interactions, and brain pathologies. New York: Plenum Press, 1996.
Знайти повний текст джерелаЧастини книг з теми "Blood-brain barrier"
Tran, Nam. "Blood-Brain Barrier." In Encyclopedia of Clinical Neuropsychology, 601–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_299.
Повний текст джерелаTyrer, Peter J., Mark Slifstein, Joris C. Verster, Kim Fromme, Amee B. Patel, Britta Hahn, Christer Allgulander, et al. "Blood–Brain Barrier." In Encyclopedia of Psychopharmacology, 241–45. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_387.
Повний текст джерелаTran, Nam. "Blood-Brain Barrier." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56782-2_299-2.
Повний текст джерелаScherrmann, Jean-Michel. "Blood–Brain Barrier." In Encyclopedia of Psychopharmacology, 302–8. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-36172-2_387.
Повний текст джерелаAvraham, Shalom, Tzong-Shi Lu, and Hava Karsenty Avraham. "Blood-Brain Barrier." In Encyclopedia of Cancer, 1–5. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_669-2.
Повний текст джерелаAlemanno, Fernando. "Blood–Brain Barrier." In Biochemistry for Anesthesiologists and Intensivists, 71–74. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-26721-6_7.
Повний текст джерелаLeshan, Rebecca, Teri Milner, and Donald W. Pfaff. "Blood-Brain Barrier." In Neuroscience in the 21st Century, 1911–20. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3474-4_129.
Повний текст джерелаLeshan, Rebecca, Teri Milner, and Donald W. Pfaff. "Blood-Brain Barrier." In Neuroscience in the 21st Century, 1–10. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-6434-1_129-3.
Повний текст джерелаLeshan, Rebecca, Teresa A. Milner, and Donald W. Pfaff. "Blood-Brain Barrier." In Neuroscience in the 21st Century, 1–10. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4614-6434-1_129-4.
Повний текст джерелаAvraham, Shalom, Tzong-Shi Lu, and Hava Karsenty Avraham. "Blood-Brain Barrier." In Encyclopedia of Cancer, 556–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_669.
Повний текст джерелаТези доповідей конференцій з теми "Blood-brain barrier"
Saharov, D. "CREATION OF IN VITRO MODEL OF HUMAN BLOOD-BRAIN BARRIER, COMPLETELY IDENTIFICAL TO REAL BLOOD-BRAIN BARRIER." In 19th SGEM International Multidisciplinary Scientific GeoConference EXPO Proceedings. STEF92 Technology, 2019. http://dx.doi.org/10.5593/sgem2019/6.1/s24.019.
Повний текст джерелаChaing, Ya-Yu, and Kai-Hong Tu. "In Vitro Microfluidics-based Blood–brain Barrier Model." In 2019 IEEE 14th International Conference on Nano/Micro Engineered and Molecular Systems (NEMS). IEEE, 2019. http://dx.doi.org/10.1109/nems.2019.8915667.
Повний текст джерелаChen, Dechang, Jianwen Fang, and Jiawei Yu. "Predicting Blood-Brain Barrier Penetration by Stochastic Discrimination." In 2008 International Conference on Biomedical Engineering And Informatics (BMEI). IEEE, 2008. http://dx.doi.org/10.1109/bmei.2008.243.
Повний текст джерелаGuanglei Li, Wei Yuan, and Bingmei M. Fu. "A transport model for the blood-brain barrier." In 2007 IEEE 33rd Annual Northeast Bioengineering Conference. IEEE, 2007. http://dx.doi.org/10.1109/nebc.2007.4413342.
Повний текст джерелаLi, Guanglei, Melissa J. Simon, Limary Cancel, Zhong-Dong Shi, Xinyi Ji, John M. Tarbell, Barclay Morrison, and Bingmei M. Fu. "Permeability of in vitro blood-brain barrier models." In 2010 36th Annual Northeast Bioengineering Conference. IEEE, 2010. http://dx.doi.org/10.1109/nebc.2010.5458260.
Повний текст джерелаChoi, James J. "Noninvasive Blood-Brain Barrier Opening in Live Mice." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205480.
Повний текст джерелаHynynen, Kullervo. "Notice of Removal: Breaching the blood-brain barrier noninvasively." In 2017 IEEE International Ultrasonics Symposium (IUS). IEEE, 2017. http://dx.doi.org/10.1109/ultsym.2017.8092834.
Повний текст джерелаSaharov, D. A. "DEVELOPMENT OF CELLULAR MODEL OF HUMAN BLOOD-BRAIN BARRIER." In 19th SGEM International Multidisciplinary Scientific GeoConference EXPO Proceedings. STEF92 Technology, 2019. http://dx.doi.org/10.5593/sgem2019/6.1/s25.085.
Повний текст джерелаKline-Schoder, Alina R., Sana Chintamen, Vilas Menon, Steven G. Kernie, and Elisa E. Konofagou. "Focused-ultrasound blood-brain barrier opening promotes neuroprotective microglia." In 2022 IEEE International Ultrasonics Symposium (IUS). IEEE, 2022. http://dx.doi.org/10.1109/ius54386.2022.9958101.
Повний текст джерелаDavalos, Dimitrios. "Microglial Responses to Blood Brain Barrier Disruption in Neuroinflammatory Disease." In Optics and the Brain. Washington, D.C.: OSA, 2016. http://dx.doi.org/10.1364/brain.2016.bth3d.5.
Повний текст джерелаЗвіти організацій з теми "Blood-brain barrier"
Aschner, Michael. Blood-Brain Barrier Transport of Uranium. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada433990.
Повний текст джерелаAschner, Michael. Blood-Brain Barrier Transport of Uranium. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada412998.
Повний текст джерелаAschner, Michael. Blood-Brain Barrier Transport of Uranium. Fort Belvoir, VA: Defense Technical Information Center, September 2003. http://dx.doi.org/10.21236/ada422003.
Повний текст джерелаGoldman, Harold, and Robert F. Berman. Regional Blood-Brain Barrier Responses to Central Cholinergic Activity. Fort Belvoir, VA: Defense Technical Information Center, June 1991. http://dx.doi.org/10.21236/ada246911.
Повний текст джерелаZhang, Luwen. Epstein Barr Virus and Blood Brain Barrier in Multiple Sclerosis. Fort Belvoir, VA: Defense Technical Information Center, July 2013. http://dx.doi.org/10.21236/ada593294.
Повний текст джерелаZhang, Luwen. Epstein Barr Virus and Blood Brain Barrier in Multiple Sclerosis. Fort Belvoir, VA: Defense Technical Information Center, January 2014. http://dx.doi.org/10.21236/ada596844.
Повний текст джерелаGoldstein, L. B., A. M. Dechovskaia, S. Bullman, K. H. Jones, and A. A. Abdel-Rahman. Daily Dermal Co-Exposure of Rats to DEET and Permethrin Produces Sensorimotor Deficit, and Changes in Blood-Brain Barrier (BBB) and Blood-Testis Barrier (BTB). Fort Belvoir, VA: Defense Technical Information Center, March 2001. http://dx.doi.org/10.21236/ada402081.
Повний текст джерелаAvraham, Hava. Oxidative Stress Increases the Blood Brain Barrier Permeability Resulting in Increased Incidence of Brain Metastasis in BRCA Mutation Carriers. Fort Belvoir, VA: Defense Technical Information Center, February 2013. http://dx.doi.org/10.21236/ada576308.
Повний текст джерелаAvraham, Hava. Oxidative Stress Increases the Blood Brain Barrier Permeability Resulting in Increased Incidence of Brain Metastasis in BRCA Mutation Carriers. Fort Belvoir, VA: Defense Technical Information Center, February 2012. http://dx.doi.org/10.21236/ada560888.
Повний текст джерелаChoi, Hannah. The Review of Central Nervous System Drug Delivery Through the Blood Brain Barrier using Nanoparticles for Treatment of Brain Diseases. Ames (Iowa): Iowa State University, May 2023. http://dx.doi.org/10.31274/cc-20240624-1482.
Повний текст джерела